ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Inozyme Pharma Inc

Inozyme Pharma Inc (INZY)

1.35
-0.03
( -2.17% )
更新日時: 00:08:09

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
1.35
買値
1.34
売値
1.35
出来高
186,150
1.32 日の範囲 1.445
1.32 52 週間の範囲 7.795
時価総額
前日終値
1.38
始値
1.41
最終取引時間
00:08:08
財務取引量
US$ 256,859
VWAP
1.3799
平均取引量 (3 か月)
654,793
発行済株式数
64,240,198
配当利回り
-
PER
-1.22
1 株当たり利益 (EPS)
-1.11
歳入
-
純利益
-71.17M

Inozyme Pharma Inc について

Inozyme Pharma Inc is a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue and skeleton. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 ... Inozyme Pharma Inc is a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue and skeleton. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, or genetically engineered, fusion protein that is designed to correct a defect in the mineralization pathway caused by ENPP1 and ABCC6 deficiencies. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
Inozyme Pharma Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker INZY. The last closing price for Inozyme Pharma was US$1.38. Over the last year, Inozyme Pharma shares have traded in a share price range of US$ 1.32 to US$ 7.795.

Inozyme Pharma currently has 64,240,198 shares in issue. The market capitalisation of Inozyme Pharma is US$88.65 million. Inozyme Pharma has a price to earnings ratio (PE ratio) of -1.22.

INZY 最新ニュース

Inozyme Pharma Announces Positive Interim Data for INZ-701 in Infants and Young Children with ENPP1 Deficiency and Key Program Updates

- Positive interim results in infants and young children with ENPP1 Deficiency showed improvements from baseline in multiple measures of disease, including survival, heart function, and...

Inozyme Pharma to Participate in the Piper Sandler 36th Annual Healthcare Conference

BOSTON, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“the Company” or “Inozyme”), a clinical-stage biopharmaceutical company developing innovative therapeutics for rare...

Inozyme Pharma to Present at Upcoming Investor Conferences

BOSTON, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“the Company” or “Inozyme”), a clinical-stage biopharmaceutical company developing innovative therapeutics for rare...

Inozyme Pharma Reports Third Quarter 2024 Financial Results and Provides Business Highlights

- Interim data from ENERGY 1, a Phase 1b trial of INZ-701 in infants with ENPP1 Deficiency, on track for fourth quarter of 2024 – - Topline data from ENERGY 3, a pivotal trial of INZ-701 in...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-1.36-50.1845018452.712.74431.3216117501.70459748CS
4-1.46-51.95729537372.813.181.327313562.28693058CS
12-3.59-72.67206477734.945.161.326547932.82416168CS
26-4.21-75.71942446045.566.241.324292383.59722079CS
52-2.79-67.39130434784.147.7951.324734234.59564736CS
156-5.3-79.69924812036.657.980.9914886124.19593744CS
260-16.58-92.470719464617.9331.64990.9913489275.08836125CS

INZY - Frequently Asked Questions (FAQ)

What is the current Inozyme Pharma share price?
The current share price of Inozyme Pharma is US$ 1.35
How many Inozyme Pharma shares are in issue?
Inozyme Pharma has 64,240,198 shares in issue
What is the market cap of Inozyme Pharma?
The market capitalisation of Inozyme Pharma is USD 88.65M
What is the 1 year trading range for Inozyme Pharma share price?
Inozyme Pharma has traded in the range of US$ 1.32 to US$ 7.795 during the past year
What is the PE ratio of Inozyme Pharma?
The price to earnings ratio of Inozyme Pharma is -1.22
What is the reporting currency for Inozyme Pharma?
Inozyme Pharma reports financial results in USD
What is the latest annual profit for Inozyme Pharma?
The latest annual profit of Inozyme Pharma is USD -71.17M
What is the registered address of Inozyme Pharma?
The registered address for Inozyme Pharma is CORPORATION TRUST CENTER 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the Inozyme Pharma website address?
The website address for Inozyme Pharma is www.inozyme.com
Which industry sector does Inozyme Pharma operate in?
Inozyme Pharma operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
BMRABiomerica Inc
US$ 1.01
(188.57%)
214.74M
DATSDatChat Inc
US$ 6.56
(53.99%)
15.5M
WHLRWheeler Real Estate Investment Trust Inc
US$ 3.545
(50.85%)
67.41M
ARQQArqit Quantum Inc
US$ 26.80
(30.16%)
1.14M
DOYUDouYu International Holdings Ltd
US$ 15.90
(29.37%)
1.25M
LFLYLeafly Holdings Inc
US$ 0.7593
(-47.27%)
174.56k
ATRAAtara Biotherapeutics Inc
US$ 7.1775
(-45.46%)
811.2k
LUXHLuxUrban Hotels Inc
US$ 0.384249
(-44.16%)
1.22M
PTLEPTL Ltd
US$ 3.1264
(-28.13%)
1.3M
YYAIConnexa Sports Technologies Inc
US$ 0.93564
(-23.93%)
397.19k
ADTXAditxt Inc
US$ 0.1475
(12.60%)
236.14M
BMRABiomerica Inc
US$ 1.01
(188.57%)
214.74M
ACONAclarion Inc
US$ 0.0479
(12.71%)
184.15M
RGTIRigetti Computing Inc
US$ 11.4024
(4.23%)
92.29M
WHLRWheeler Real Estate Investment Trust Inc
US$ 3.5599
(51.49%)
67.42M

INZY Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock